{"id":5479,"date":"2021-03-22T10:28:08","date_gmt":"2021-03-22T17:28:08","guid":{"rendered":"https:\/\/qualigendiagnostics.com\/staging\/9074\/?p=5479"},"modified":"2022-01-28T21:55:27","modified_gmt":"2022-01-29T05:55:27","slug":"ira-e-ritter","status":"publish","type":"post","link":"https:\/\/qualigendiagnostics.com\/staging\/9074\/ira-e-ritter\/","title":{"rendered":"Ira E. Ritter: Director"},"content":{"rendered":"\n

Mr. Ritter served as Co-Founder, Chief Strategic Officer and Executive Chairman of Ritter\u2019s predecessor from its inception in 2004 through the formation of Ritter Pharmaceuticals, Inc. in 2008 and he has served in those positions with Ritter since 2008. Mr. Ritter has extensive experience creating and building diverse business enterprises and has provided corporate management, strategic planning and financial consulting for a wide range of market segments including, health product related national distribution and private label production, television and publishing. He assisted taking Ritter public on Nasdaq and Martin Lawrence Art Galleries public on the The New York Stock Exchange. Since 2010, Mr. Ritter has also acted as a managing partner of Stonehenge Partners. Mr. Ritter has a long history of public service that includes appointments by three Governors to several State of California Commissions including eight years as Commissioner on the California Prison Industry Authority. He has guest lectured at University of Southern California Marshall School of Business and Pepperdine University Graziadio School of Business, where he also serves as an advisory board member to Pepperdine\u2019s Graduate School of Education and Psychology, Social Entrepreneurship and Change Program. He has served on the boards of directors for Vitavis Laboratories and SCWorx.<\/p>\n\n\n\n